InvestorsHub Logo
icon url

Rdunn88

03/23/21 11:00 AM

#353011 RE: Phoenix300 #353002

B's revenue potential drops by the thousands each day as high-risk candidates are vaccinated. Many others with less side effects won't need B as well. Unless Leo gets fast approval after P2 they would be wasting millions running a P3 in 2022.